ReviewHematology/oncology clinics of North America2022

The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease.

Kristie Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.